Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection
Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection：a Multi-center Cohort Study in China
Sponsor: Fujian Maternity and Child Health Hospital
Listed as NCT05283239, this observational or N/A phase trial focuses on HPV Infection and HSIL, High-Grade Squamous Intraepithelial Lesions and remains ongoing. Sponsored by Fujian Maternity and Child Health Hospital, it has been updated 5 times since 2022, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Jan 2026 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Jan 2026 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Apr 2022 — Dec 2023 [monthly]
Recruiting
First recorded
Jan 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fujian Maternity and Child Health Hospital
For direct contact, visit the study record on ClinicalTrials.gov .